학술논문

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
Document Type
Artikel
Source
Blood. 136(18):2038-2050
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1528-0020